Related Experiment Video
Updated: Jun 10, 2026

Detection of Alternative Splicing During Epithelial-Mesenchymal Transition
Published on: October 9, 2014
An alternative splicing network links cell-cycle control to apoptosis
Michael J Moore1, Qingqing Wang, Caleb J Kennedy
1Department of Systems Biology, Harvard Medical School, Boston, MA 02115, USA.
Abstract:
Alternative splicing is a vast source of biological regulation and diversity that is misregulated in cancer and other diseases. To investigate global control of alternative splicing in human cells, we analyzed splicing of mRNAs encoding Bcl2 family apoptosis factors in a genome-wide siRNA screen. The screen identified many regulators of Bcl-x and Mcl1 splicing, notably an extensive network of cell-cycle factors linked to aurora kinase A. Drugs or siRNAs that induce mitotic arrest promote proapoptotic splicing of Bcl-x, Mcl1, and caspase-9 and alter splicing of other apoptotic transcripts. This response precedes mitotic arrest, indicating coordinated upregulation of prodeath splice variants that promotes apoptosis in arrested cells. These shifts correspond to posttranslational turnover of splicing regulator ASF/SF2, which directly binds and regulates these target mRNAs and globally regulates apoptosis. Broadly, our results reveal an alternative splicing network linking cell-cycle control to apoptosis.
Insights
Alternative splicing regulates cell death and is disrupted in diseases. This study reveals a network linking cell-cycle control to apoptosis through alternative splicing of key genes.
Area of Science:
- Molecular Biology
- Cell Biology
- Genetics
Background:
- Alternative splicing is a key mechanism for biological regulation and diversity.
- Dysregulation of alternative splicing is implicated in various diseases, including cancer.
- The Bcl2 family of apoptosis factors plays a critical role in programmed cell death.
Purpose of the Study:
- To investigate the global control of alternative splicing in human cells.
- To identify regulators of alternative splicing for Bcl-x and Mcl1 mRNA.
- To understand the link between cell-cycle control and apoptosis via splicing.
Main Methods:
- Genome-wide siRNA screen to identify splicing regulators.
- Analysis of mRNA splicing patterns for Bcl2 family apoptosis factors.
- Investigation of the role of cell-cycle factors and aurora kinase A.
Main Results:
- A network of cell-cycle factors, including aurora kinase A, was identified as regulators of Bcl-x and Mcl1 splicing.
- Mitotic arrest induced by drugs or siRNAs promoted proapoptotic splicing of Bcl-x, Mcl1, and caspase-9.
- Posttranslational turnover of splicing regulator ASF/SF2 correlated with shifts in splice variants, impacting apoptosis.
Conclusions:
- A novel alternative splicing network links cell-cycle control to apoptosis.
- Coordinated upregulation of prodeath splice variants promotes apoptosis in cells undergoing mitotic arrest.
- Splicing regulator ASF/SF2 plays a global role in regulating apoptosis through alternative splicing.
Related Concept Videos
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
RNA Splicing
RNA Splicing
The Cell Cycle Control System
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and function at the cell...
The Cell Cycle Control System

